Sylvia Bartel is the new senior vice president of pharmacy and chief pharmacy officer at Dana-Farber Cancer Institute
Sylvia Bartel is the chief pharmacy officer and senior vice president of pharmacy at the Dana-Farber Cancer Institute.
She is also the Director of the Research Core of DF/HCC. She is also responsible for the inpatient hematology/oncology pharmacy services at Brigham and Women’s Hospital.
She received her BS in pharmacy at the University of Wisconsin and an MS in public health from Northeastern University. Sylvia’s professional interests include oncology and therapeutic guideline development.
Dana-Farber Cancer Institute shared a post on LinkedIn about Sylvia Bartel:
“Sylvia Bartel has been promoted to senior vice president of pharmacy and chief pharmacy officer. Sylvia has been an invaluable leader in the Department of Pharmacy and has played a pivotal role in numerous milestones that significantly advanced our institution. We look forward to her continued leadership and the impact she will have on advancing the role of Pharmacy at our Institute and beyond.”
For more such information, visit oncodaily.com.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023